Tag Archive for ‘breast cancer’
Summarizes the shared scientific mission of the CompassHER2 Trials, which is to optimize systemic therapy for patients with clinical stage II–III HER2+ early-stage breast cancer.
Describes the development and goals of the SharEs study, which aims to enhance patient-centered communication for breast cancer patients.
The goals of the ACS Your Breast Cancer Surgery Program are summarized as are the measures for defining this patient education program’s success.
NCDB trends in young women with metastatic breast cancer diagnosis since screening guideline changes were instituted
Early detection of breast cancer by mammography allows women to access more favorable treatment options and has resulted in an overall reduction in mortality of approximately 20 percent to 40 percent and improved survival.1 In 2009, the U.S. Preventive Services Task Force (USPSTF) changed breast cancer screening guidelines for mammograms from every one year to […]
The evolution of genetic testing for breast cancer patients is outlined, including the American Society of Breast Surgeons consensus guidelines and the potential implications of germline genetic mutation detection on surgical management.
Appropriate surveillance and risk-reduction strategies for atypical ductal hyperplasia or lobular neoplasia are discussed.
Eliminating financial barriers and improving access to care will improve the health of individuals with or at risk for breast cancer.
The inaugural recipient of the American College of Surgeons/American Society of Breast Surgeons International Scholarship is Juan José Cossa Morchio, MD, FACS, a general surgeon at Clinics Hospital, Montevideo, Uruguay.
Historically, neoadjuvant systemic therapy (NST) has been mainly used to convert breast cancer from inoperable to operable; however, today NST also is incorporated into the treatment of patients who initially present with operable disease. NST can allow some patients with stage II-III breast cancer who initially present with disease extent necessitating mastectomy to possibly undergo […]
Response to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options
The uptake of neoadjuvant endocrine therapy in the U.S. has been slow according to the authors of this month’s column, even though this treatment can reduce the extent of breast surgery.
A new manual, Operative Standards for Cancer Surgery, provides evidence-based standards for various cancer procedures and is described in this month’s column.
The ACS Oncology Group Z1071 trial and sentinel lymph node surgery in clinically node-positive patients receiving neoadjuvant chemotherapy are examined in this month’s column.
To overcome inconsistencies in cancer care, the development, measurement, and reporting of quality measures are essential. This article highlights the efforts of the ACS Commission on Cancer and its collaboration with other societies involved in defining and measuring breast cancer care.
The National Accreditation Program for Breast Centers has accredited more than 500 breast centers.
Magnetic resonance imaging (MRI) has been used to manage breast cancer for more than two decades. Despite this familiarity, or perhaps because of it, the controversy over the utility of breast MRI has continued to grow. Early reports showed that breast MRI had the ability to detect disease that mammography otherwise missed. These early reports […]